Balci, Melih <br/><br/>
Use of the nuclear matrix protein 22 Bladder Chek test™ in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer.  [electronic resource] 

 -  International urology and nephrology  Mar 2015 
 - 473-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-2584 
<br/><br/><label>Standard No.: </label>10.1007/s11255-015-0921-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--urine<br/>Carcinoma--diagnosis<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm, Residual<br/>Nuclear Proteins--urine<br/>Predictive Value of Tests<br/>Prospective Studies<br/>Reoperation<br/>Urinary Bladder Neoplasms--diagnosis<br/>Urine--cytology<br/>Urothelium<br/>Young Adult